Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00098748
Status:
COMPLETED
Last Update Posted:
2010-12-07
First Post:
2004-12-07
Brief Title:
Trial of Maraviroc UK-427857 in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects
Sponsor:
ViiV Healthcare
Organization:
ViiV Healthcare
Organization Data
Organization:
ViiV Healthcare
Class:
INDUSTRY
Study ID:
A4001029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ViiV Healthcare
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |